Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page
- CheckyesterdayChange DetectedAdded Principal Investigator and Last Update Posted (Estimated) fields; updated the study title display. Removed the old Contact field and the prior Last Update Posted information.SummaryDifference0.5%

- Check8 days agoChange DetectedA new 'Locations' section was added listing California, Oregon, Utah, and Washington sites, and the previous state-specific location entries were removed; revision updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive changes to study details or functionality were observed.SummaryDifference0.1%

- Check37 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page no longer displays a government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedNo significant additions or deletions were detected; page content, including study details and eligibility criteria, appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.